OTCMKTS:AXIM

AXIM Biotechnologies Competitors

$0.65
+0.02 (+3.08 %)
(As of 04/9/2021 08:27 PM ET)
Add
Compare
Today's Range
$0.63
Now: $0.65
$0.66
50-Day Range
$0.57
MA: $0.68
$0.82
52-Week Range
$0.12
Now: $0.65
$1.44
Volume24,900 shs
Average Volume300,904 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Competitors

AXIM Biotechnologies (OTCMKTS:AXIM) Vs. DDXS, TNGN, ATTBF, ACHL, ADTX, and AGNPF

Should you be buying AXIM stock or one of its competitors? Companies in the industry of "biotechnology" are considered alternatives and competitors to AXIM Biotechnologies, including (DDXS) (DDXS), (TNGN) (TNGN), Abattis Bioceuticals (ATTBF), Achilles Therapeutics plc American Depositary Shares (ACHL), ADiTx Therapeutics (ADTX), and Algernon Pharmaceuticals (AGNPF).

(DDXS) (OTCMKTS:DDXS) and AXIM Biotechnologies (OTCMKTS:AXIM) are both health technology companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, profitability, valuation, analyst recommendations, dividends, earnings and risk.

Valuation and Earnings

This table compares (DDXS) and AXIM Biotechnologies' top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
(DDXS)N/AN/AN/AN/AN/A
AXIM BiotechnologiesN/AN/AN/AN/AN/A

Profitability

This table compares (DDXS) and AXIM Biotechnologies' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
(DDXS)N/AN/AN/A
AXIM BiotechnologiesN/AN/AN/A

Analyst Ratings

This is a breakdown of recent ratings and recommmendations for (DDXS) and AXIM Biotechnologies, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
(DDXS)0000N/A
AXIM Biotechnologies0000N/A

(TNGN) (OTCMKTS:TNGN) and AXIM Biotechnologies (OTCMKTS:AXIM) are both health technology companies, but which is the better business? We will compare the two companies based on the strength of their profitability, institutional ownership, valuation, risk, analyst recommendations, earnings and dividends.

Earnings & Valuation

This table compares (TNGN) and AXIM Biotechnologies' top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
(TNGN)N/AN/AN/AN/AN/A
AXIM BiotechnologiesN/AN/AN/AN/AN/A

Profitability

This table compares (TNGN) and AXIM Biotechnologies' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
(TNGN)N/AN/AN/A
AXIM BiotechnologiesN/AN/AN/A

Analyst Recommendations

This is a breakdown of recent recommendations for (TNGN) and AXIM Biotechnologies, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
(TNGN)0000N/A
AXIM Biotechnologies0000N/A

Abattis Bioceuticals (OTCMKTS:ATTBF) and AXIM Biotechnologies (OTCMKTS:AXIM) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their profitability, institutional ownership, valuation, risk, analyst recommendations, earnings and dividends.

Analyst Recommendations

This is a breakdown of recent recommendations for Abattis Bioceuticals and AXIM Biotechnologies, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Abattis Bioceuticals0000N/A
AXIM Biotechnologies0000N/A

Earnings & Valuation

This table compares Abattis Bioceuticals and AXIM Biotechnologies' top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Abattis BioceuticalsN/AN/AN/AN/AN/A
AXIM BiotechnologiesN/AN/AN/AN/AN/A

Profitability

This table compares Abattis Bioceuticals and AXIM Biotechnologies' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Abattis BioceuticalsN/AN/AN/A
AXIM BiotechnologiesN/AN/AN/A

AXIM Biotechnologies (OTCMKTS:AXIM) and Achilles Therapeutics plc American Depositary Shares (NASDAQ:ACHL) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, dividends, valuation, risk, analyst recommendations, earnings and profitability.

Analyst Ratings

This is a summary of recent ratings for AXIM Biotechnologies and Achilles Therapeutics plc American Depositary Shares, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
AXIM Biotechnologies0000N/A
Achilles Therapeutics plc American Depositary Shares0000N/A

Earnings and Valuation

This table compares AXIM Biotechnologies and Achilles Therapeutics plc American Depositary Shares' gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
AXIM BiotechnologiesN/AN/AN/AN/AN/A
Achilles Therapeutics plc American Depositary SharesN/AN/AN/AN/AN/A

Profitability

This table compares AXIM Biotechnologies and Achilles Therapeutics plc American Depositary Shares' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
AXIM BiotechnologiesN/AN/AN/A
Achilles Therapeutics plc American Depositary SharesN/AN/AN/A

AXIM Biotechnologies (OTCMKTS:AXIM) and ADiTx Therapeutics (NASDAQ:ADTX) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, dividends, valuation, risk, analyst recommendations, earnings and profitability.

Analyst Ratings

This is a summary of recent ratings for AXIM Biotechnologies and ADiTx Therapeutics, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
AXIM Biotechnologies0000N/A
ADiTx Therapeutics00103.00

Earnings and Valuation

This table compares AXIM Biotechnologies and ADiTx Therapeutics' gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
AXIM BiotechnologiesN/AN/AN/AN/AN/A
ADiTx TherapeuticsN/AN/AN/AN/AN/A

Profitability

This table compares AXIM Biotechnologies and ADiTx Therapeutics' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
AXIM BiotechnologiesN/AN/AN/A
ADiTx TherapeuticsN/AN/AN/A

Summary

ADiTx Therapeutics beats AXIM Biotechnologies on 1 of the 1 factors compared between the two stocks.

AXIM Biotechnologies (OTCMKTS:AXIM) and Algernon Pharmaceuticals (OTCMKTS:AGNPF) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, dividends, valuation, risk, analyst recommendations, earnings and profitability.

Analyst Ratings

This is a summary of recent ratings for AXIM Biotechnologies and Algernon Pharmaceuticals, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
AXIM Biotechnologies0000N/A
Algernon Pharmaceuticals0000N/A

Earnings and Valuation

This table compares AXIM Biotechnologies and Algernon Pharmaceuticals' gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
AXIM BiotechnologiesN/AN/AN/AN/AN/A
Algernon PharmaceuticalsN/AN/AN/AN/AN/A

Profitability

This table compares AXIM Biotechnologies and Algernon Pharmaceuticals' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
AXIM BiotechnologiesN/AN/AN/A
Algernon PharmaceuticalsN/AN/AN/A


AXIM Biotechnologies Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
(DDXS) logo
DDXS
(DDXS)
0.5$0.01+53.8%$0.00N/A0.00High Trading Volume
Gap Up
TNGN
(TNGN)
0.4N/AN/A$0.00N/A0.00Gap Up
Abattis Bioceuticals logo
ATTBF
Abattis Bioceuticals
0.4$0.02+2.6%$0.00N/A0.00
ACHL
Achilles Therapeutics plc American Depositary Shares
0.0$13.78+5.3%$0.00N/A0.00
ADiTx Therapeutics logo
ADTX
ADiTx Therapeutics
1.0$2.94+0.7%$0.00N/A0.00
Algernon Pharmaceuticals logo
AGNPF
Algernon Pharmaceuticals
0.0$0.15+1.2%$0.00N/A0.00Gap Down
Almirall logo
LBTSF
Almirall
0.5$15.00+1.3%$0.00N/A0.00
Apotheca Biosciences logo
CBDC
Apotheca Biosciences
0.4$0.08+0.0%$0.00N/A0.00
ARNI
Arno Therapeutics
0.5$0.01+0.0%$0.00N/A0.00Gap Up
ASCLF
Ascletis Pharma
0.4$0.37+0.0%$0.00N/A0.00
Avid Bioservices logo
CDMOP
Avid Bioservices
0.3$25.06+0.0%$0.00N/A0.00
BXRXV
Baudax Bio
0.5$4.51+22.2%$0.00N/A0.00High Trading Volume
BRRGF
BerGenBio ASA
0.7$3.52+10.2%$0.00N/A0.00Gap Up
Cannabics Pharmaceuticals logo
CNBX
Cannabics Pharmaceuticals
0.4$0.25+14.0%$0.00N/A0.00Gap Up
ORHOF
CannaRoyalty
0.7$9.23+56.1%$0.00N/A0.00Gap Down
Cerebain Biotech logo
CBBT
Cerebain Biotech
0.0$0.06+31.9%$0.00N/A0.00
CGYG
China Longyi Group International
0.4$0.00+0.0%$0.00N/A0.00High Trading Volume
CLVLY
Clinuvel Pharmaceuticals
1.0$22.86+1.6%$0.00N/A0.00
CELZ
Creative Medical Technology
0.5$0.05+7.9%$0.00N/A0.00
Cybin logo
CLXPF
Cybin
1.0$1.34+1.5%$0.00N/A0.00Gap Up
Eastgate Biotech logo
ETBI
Eastgate Biotech
0.5$0.00+75.0%$0.00N/A0.00High Trading Volume
Gap Up
EMMBF
Emblem
0.6$1.40+1.4%$0.00N/A0.00
ENZC
Enzolytics
0.0$0.23+18.0%$0.00N/A0.00Gap Down
GB Sciences logo
GBLX
GB Sciences
0.5$0.06+1.9%$0.00N/A0.00
Genfit logo
GNFTF
Genfit
0.5$4.65+4.7%$0.00N/A0.00Gap Up
GMXAY
GENMAB A/S/S
0.5$18.35+0.9%$0.00N/A0.00
Genus logo
GENSF
Genus
0.7$69.40+7.0%$0.00N/A0.00Gap Up
HALB
Halberd
0.0$0.04+5.7%$0.00N/A0.00Gap Down
HAVN Life Sciences logo
HAVLF
HAVN Life Sciences
0.0$0.58+1.0%$0.00N/A0.00Gap Down
Idorsia logo
IDRSF
Idorsia
0.5$27.18+0.7%$0.00N/A0.00
IPATF
ImmunoPrecise Antibodies
0.5$18.70+0.5%$0.00N/A0.00High Trading Volume
IMLFF
InMed Pharmaceuticals
0.6$4.88+1.6%$0.00N/A0.00High Trading Volume
News Coverage
Innovation Pharmaceuticals logo
IPIX
Innovation Pharmaceuticals
0.6$0.27+0.7%$0.00N/A0.00Gap Down
Kalytera Therapeutics logo
KALTF
Kalytera Therapeutics
0.6$0.03+5.3%$0.00N/A0.00Gap Down
Medican Enterprises logo
MDCN
Medican Enterprises
0.5$0.00+10.0%$0.00N/A0.00Gap Up
Mesoblast logo
MEOBF
Mesoblast
0.5$1.67+3.5%$0.00N/A0.00
MCURF
Mind Cure Health
0.0$0.38+5.7%$0.00N/A0.00
Mind Medicine (MindMed) logo
MMEDF
Mind Medicine (MindMed)
1.1$2.69+3.0%$0.00N/A0.00
Molecular Partners logo
MLLCF
Molecular Partners
0.5$24.70+5.2%$0.00N/A0.00Gap Up
MPSYF
MorphoSys
0.0$88.15+13.4%$0.00N/A0.00Gap Up
NRNVF
Nordic Nanovector ASA
0.0$1.64+0.0%$0.00N/A0.00High Trading Volume
Novozymes A/S logo
NVZMF
Novozymes A/S
0.4$65.81+0.3%$0.00N/A0.00
BPSR
Organicell Regenerative Medicine
0.5$0.06+2.6%$0.00N/A0.00
Oxurion logo
TBGNF
Oxurion
0.5$2.75+1.4%$0.00N/A0.00
Pharnext logo
PNEXF
Pharnext
0.0$4.11+4.4%$0.00N/A0.00High Trading Volume
Gap Up
PTEO
Proteo
0.5$178.00+1.0%$0.00N/A0.00High Trading Volume
PROT
Proteonomix
0.5$0.01+4.2%$0.00N/A0.00
PKTX
ProtoKinetix
0.5$0.25+2.1%$0.00N/A0.00High Trading Volume
Gap Down
PureTech Health logo
PTCHF
PureTech Health
0.0$5.85+1.9%$0.00N/A0.00
RCPHF
Recipharm AB (publ)
1.0$16.05+8.5%$0.00N/A0.00High Trading Volume
Gap Up
This page was last updated on 4/12/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.